Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Squamous Cell Carcinoma Esophagus: Demographics and Evaluation of Prognostic Factors at a Tertiary Care Center in India

被引：0

作者：

Mithi, Mohamed Taher ^{[1
]}

Sharma, Mohit ^{[1
]}

Puj, Ketul ^{[1
]}

Hazarika, Prandweep ^{[1
]}

Pandya, Shashank J. ^{[1
]}

Gandhi, Jahnavi ^{[2
]}

Parikh, Ankita ^{[3
]}

Shukla, Shivang ^{[1
]}

机构：

[1] Gujarat Canc Res Inst, Dept Surg Oncol, Ahmadabad 380016, Gujarat, India

[2] Gujarat Canc Res Inst, Dept Pathol, Ahmadabad 380016, Gujarat, India

[3] Gujarat Canc Res Inst, Dept Radiotherapy, Ahmadabad 380016, Gujarat, India

来源：

INDIAN JOURNAL OF SURGICAL ONCOLOGY | 2024年 / 15卷 / 01期

关键词：

Esophageal cancer; Neoadjuvant chemoradiation; Pathological complete response; Squamous cell carcinoma; Esophagectomy; PATHOLOGICAL COMPLETE RESPONSE; ADVANCED RESECTABLE CARCINOMA; WALL THICKNESS; SINGLE-CENTER; CHEMORADIOTHERAPY; SURVIVAL; CANCER; TRENDS;

D O I：

10.1007/s13193-023-01828-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Neoadjuvant chemoradiation followed by surgery has been the standard of care for locally advanced carcinoma esophagus. We present our experience and inference of various factors associated with the same treatment and the prognostic influence of the same. A retrospective analysis of a cohort of 132 squamous cell carcinoma esophagus patients post neoadjuvant chemoradiation operated with curative intent was carried out. The 2-year overall survival rate was 64.5%. A pathological complete response was achieved in 32.5% of patients and was the only factor that significantly determined overall survival (p = 0.048). Neoadjuvant chemoradiation before surgery for locally advanced squamous cell cancer of the esophagus remains the standard of care with a pathological complete response being a significant factor in predicting overall survival. More prospective randomized studies are necessary to analyze factors affecting and predicting a pathological complete response which would help organ preservation in patients with a complete response.

引用

页码：129 / 135

页数：7

共 50 条

[41] Evaluation of the efficacy and safety of neoadjuvant immunotherapy in locally advanced esophageal squamous cell carcinoma [J].

Wang, Mingxi ;

Wei, Dandan ;

Cui, Zhen ;

Zhou, Yangyang ;

Yin, Chuntong ;

Zhou, Zhengguang ;

D'Journo, Xavier Benoit ;

Wang, Guowen .

JOURNAL OF THORACIC DISEASE, 2025, 17 (03) :1711-1722

[42] Bayesian post-hoc analysis of chemoradiation with and without surgery in patients with focally advanced squamous cell carcinoma of the esophagus [J].

Zhou, Nicolas ;

Lee, Kyung Hyun ;

Pedroza, Claudia ;

Hofstetter, Wayne L. .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 164 (03) :688-+

[43] COST UTILITY OF DOCETAXEL AS INDUCTION CHEMOTHERAPY FOLLOWED BY CHEMORADIATION IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK [J].

Parthan, Anju ;

Posner, Marshall R. ;

Brammer, Caroline ;

Beltran, Philippe ;

Jansen, Jeroen P. .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (10) :1255-1262

[44] Clinico-epidemiological profile and treatment outcomes in patients with squamous cell carcinoma of the esophagus following docetaxel-based neoadjuvant chemotherapy: experience from a cancer care center in Northeast India [J].

Partha Sarathi Roy ;

Gaurav Kumar ;

Sreya Mallik ;

Satya Sadhan Sarangi ;

Bhargab Jyoti Saikia ;

Munlima Hazarika ;

Abhijit Talukdar .

Journal of the Egyptian National Cancer Institute, 33

[45] Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus [J].

Wang, Chen ;

Tong, Jiaqi ;

Tang, Mengqiu ;

Lu, Yunyun ;

Liang, Gaofeng ;

Zhang, Zhanchun ;

Chen, Tian .

CANCER MANAGEMENT AND RESEARCH, 2021, 13 :1075-1085

[46] Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus From the Results of NEOCRTEC5010, a Randomized Multicenter Study [J].

Leng, Xuefeng ;

He, Wenwu ;

Yang, Hong ;

Chen, Yuping ;

Zhu, Chengchu ;

Fang, Wentao ;

Yu, Zhentao ;

Mao, Weimin ;

Xiang, Jiaqing ;

Chen, Zhijian ;

Yang, Haihua ;

Wang, Jiaming ;

Pang, Qingsong ;

Zheng, Xiao ;

Liu, Hui ;

Yang, Huanjun ;

Li, Tao ;

Zhang, Xu ;

Li, Qun ;

Wang, Geng ;

Mao, Teng ;

Guo, Xufeng ;

Lin, Ting ;

Liu, Mengzhong ;

Fu, Jianhua ;

Han, Yongtao .

ANNALS OF SURGERY, 2021, 274 (06) :E1022-E1029

[47] Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by radical surgery for locally advanced oesophageal squamous cell carcinoma: meta-analysis [J].

Kamarajah, Sivesh K. ;

Evans, Richard P. T. ;

Griffiths, Ewen A. ;

Gossage, James A. ;

Pucher, Philip H. .

BJS OPEN, 2022, 6 (06)

[48] Tailoring the Treatment of Locally Advanced Squamous Cell Carcinoma of the Vulva: Neoadjuvant Chemotherapy Followed by Radical Surgery Results From a Multicenter Study [J].

Aragona, Alejandro M. ;

Cuneo, Nicasio ;

Soderini, Alejandro H. ;

Alcoba, Elsa ;

Greco, Adriana ;

Reyes, Carlos ;

Lekmann, Silvia .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (07) :1258-1263

[49] Prognostic role of pathologic status other than complete response after neoadjuvant therapy followed by surgery in esophageal squamous cell carcinoma [J].

Park, Seong Yong ;

Lee, Junghee ;

Oh, Dongryul ;

Sun, Jong-Mu ;

Yun, Jeonghee ;

Jeon, Yeong Jeong ;

Cho, Jong Ho ;

Choi, Yong Soo ;

Zo, Jae Il ;

Shim, Young Mog ;

Kim, Hong Kwan .

ESOPHAGUS, 2024, 21 (01) :51-57

[50] Neoadjuvant chemotherapy vs upfront surgery for resectable locally advanced oral squamous cell carcinoma: A retrospective single center study [J].

He, Xiaotong ;

Lei, Xiaoyue ;

Cheng, Yangxi ;

Zhu, Huiyong .

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2024,

← 1 2 3 4 5 →